Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Primary Healthcare Services

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors.

Journal of medical virology·2024

Same author

Special Issue-JSMB Marine Biotechnology 2022 Conference.

Marine biotechnology (New York, N.Y.)·2023

Same author

Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.

Cancer science·2023

Same author

Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia†.

Japanese journal of clinical oncology·2022

Same author

An ultra-sensitive label-free electrochemiluminescence CKMB immunosensor using a novel nanocomposite-modified printed electrode.

RSC advances·2022

Same author

Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.

Vaccines·2022

Search research articles

Related Experiment Video

Updated: Feb 22, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

[HPV Vaccination Program - The History and Recent Progress].

Hiroyuki Yoshikawa¹

¹Ibaraki Prefectural Central Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|September 16, 2017

Summary

This summary is machine-generated.

Japan

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Related Experiment Videos

Last Updated: Feb 22, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Area of Science:

Public Health
Immunology
Epidemiology

Background:

Japan initiated a publicly funded HPV vaccination program in 2010 for adolescent females.
In 2013, the government withdrew its recommendation due to unsubstantiated reports of adverse effects.
This led to a drastic decline in HPV vaccination coverage from 70% to 1%.

Purpose of the Study:

To review the impact of the HPV vaccination recommendation withdrawal in Japan.
To examine the scientific evidence regarding adverse effects following HPV vaccination.
To inform the decision-making process for resuming the HPV vaccination program.

Main Methods:

Analysis of HPV vaccination coverage data in Japan.
Review of scientific literature and epidemiological evidence on HPV vaccine safety.
Consideration of recent ecological investigations on adolescent symptoms.

Main Results:

No scientific evidence supports a causal link between HPV vaccines and reported post-vaccination symptoms.
Similar symptoms have been observed in unvaccinated adolescents in Japan.
Medical organizations advocate for the resumption of the HPV vaccination program.

Conclusions:

The suspension of the HPV vaccination recommendation was based on unproven claims.
Scientific evidence does not support concerns about HPV vaccine safety.
Resuming the HPV vaccination program requires a political decision informed by scientific data.